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Abstract
This paper challenges the current management of
acute traumatic spinal cord injury based on our
experience with monitoring from the injury site in the
neurointensive care unit. We argue that the concept
of bony decompression is inadequate. The concept of
optimum spinal cord perfusion pressure, which differs
between patients, is introduced. Such variability
suggests individualized patient treatment. Failing to
optimize spinal cord perfusion limits the entry of
systemically administered drugs into the injured cord.
We conclude that monitoring from the injury site
helps optimize management and should be subjected
to a trial to determine whether it improves outcome.
Keywords: Blood pressure, CNS injury, Clinical trial,
Microdialysis, Monitoring, Neurocritical care, Spinal
cord injury, Surgery
Background
Every year, 15–40 people per million suffer a traumatic
spinal cord injury (TSCI) [1]. Many TSCI patients are
initially admitted to a neurointensive care unit (NICU),
but their management is variable. This review introduces
novel concepts to aid the management of acute TSCI in
NICU based on our findings that: 1) the dura causes
spinal cord compression at the injury site; 2) each pa-
tient has an optimum spinal cord perfusion pressure;
and 3) patient position in bed influences cord perfusion.
Patient management
Surgical management
Some surgeons recommend early bony decompression,
but others do not [2, 3]. The Surgical Timing in Acute
Spinal Cord Injury Study showed better outcome at
6 months in patients who had decompressive surgery
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within 24 h compared with >24 h after cervical TSCI
[4]. This study was underpowered, not randomized, and
not blinded. In the UK [3] and internationally [2, 5]
there is no consensus on the timing or even the role of
surgery for TSCI. Below, we argue that early surgery is
controversial because surgeons perform bony decom-
pression, but fail to relieve the dural compression.
Medical and nursing management
There are no drugs that improve outcome after TSCI. The
North American Spinal Cord Injury Studies suggested that
methylprednisolone given within 8 h after TSCI improves
outcome [6, 7], but their findings have been criticized;
methylprednisolone is no longer standard of care [3, 8, 9].
The optimum mean arterial pressure (MAP) after TSCI is
unknown. The American Association of Neurological
Surgeons recommends a MAP of 85–90 mmHg for 7 days
with little supporting evidence [10]. In the UK, blood
pressure management is variable with 23 % of NICU spe-
cialists aiming for MAP >60 mmHg, 54 % >80 mmHg,
and 15 % within 20 % of what is considered normal for
age [3]. The effects on the injured cord of different anes-
thetics, altering arterial pCO2, administering vasopressors
or mannitol, and patient position in bed are also unclear.
In the UK, 96 % of neuroanesthesiologists avoid N2O [3]
which elevates intracranial pressure (ICP), though its
effect on intraspinal pressure (ISP) is unknown. Most
surgeons fix the spine and mobilize patients early [2], but
in the UK Midlands Spinal Injuries Centre patients were
kept flat for 6 weeks after TSCI with an equally good out-
comes [11]. Such variability in practice suggests that the
optimum medical and nursing management are unknown.
Below, we show how neuromonitoring may be used to
optimize management.
How to optimize management
History of monitoring from the injury site
In 2009, whilst studying the role of the water channel
protein AQP4 in TSCI in mice, Dr Saadoun noticed that
the injured cord was compressed against the dura, based
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on myelograms and ISP measurements [12]. She
wondered whether the same occurs in TSCI patients. To
investigate this, we set up a clinical trial termed Injured
Spinal Cord Pressure Evaluation (ISCoPE), aiming to
monitor ISP from the injury site in humans. By 2014, we
had monitored the ISP in 18 patients with severe TSCI
and had shown that ISP is high and potentially detri-
mental [13]. A detailed morphological and spectral ana-
lysis of the ISP signals followed [14]. Our studies led to
the idea of dural spinal cord compression that causes
compartmentalization at the injury site [15–17]. We
thus evaluated the effect of duroplasty after TSCI [18].
In 2016, we reviewed all ISCoPE patients and demon-
strated the safety and probe placement accuracy of the
technique [19]. Multi-modality monitoring from the
injury site was introduced in the same year [20], in-
cluding a novel analysis technique using Kohonen self-
organizing maps [21]. The ISCoPE studies are ongoing.
Brain versus spinal cord injury
Neuromonitoring is the standard of care for acute severe
traumatic brain injury (TBI). We use the term neuromo-
nitoring to mean monitoring ICP, tissue oxygenation,
etc., in the NICU, rather than intraoperative neuro-
physiological monitoring. Though a recent study sug-
gested that ICP monitoring does not improve outcome
[22], the findings are confounded by a delay in the start
of monitoring and no rehabilitation after discharge from
the intensive care unit. Systematic reviews suggest that
ICP monitoring in TBI reduces mortality [23] and in-
creases the chance of a favorable outcome [24]. There
are advocates of multi-modality monitoring from the in-
jury site including microdialysis (MD), oxygen, blood
flow, and electrocorticography based on the idea that
secondary damage is multifactorial and arises not only
from ischemia, but also from metabolic disturbance and
spreading depolarizations. Probes are routinely intro-
duced into the injured brain, but no such monitoring
exists for TSCI.
Several reasons may account for the lack of neuromo-
nitoring in TSCI. First, there is concern that inserting
probes exacerbates spinal cord damage. Second, spinal
probes require surgery for insertion. Third, many TSCIs
are managed by orthopedic surgeons not accustomed to
neuromonitoring. Fourth, the clinical impact of elevated
ICP is easy to detect in anesthetized brain-injured
patients as a loss of pupillary light reflex, dilated pupil,
cardiovascular instability, and, ultimately, brain death. In
contrast, increased ISP is difficult to detect in anesthe-
tized TSCI patients. This requires monitoring of motor
or sensory evoked responses, which is not routinely
done. Fifth, CT scans are routinely used in TBI to decide
management, e.g., decompressive craniectomy. In con-
trast, the injured cord is invisible on CT and, once the
spine is fixed, it is difficult to see on MRI. For these rea-
sons, ISP has not attracted the same interest as ICP.
Technique of monitoring from the injury site
The probe is inserted intradurally during surgery at the
injury site to monitor ISP for a week (Fig. 1a). The probe
cannot be inserted in the NICU, thus precluding moni-
toring non-surgical patients. ISP monitoring is tech-
nically simple and safe based on data from 42 patients
[19]. The probe is easily removed in the NICU.
The ISP and ICP waveforms are similar with three
characteristic peaks, identical Fourier transforms, and
identical shape change as ISP/ICP rise [14] (Fig. 1b).
Thus, mathematically, the ISP signal can be subjected to
the same analyses as the ICP signal [25]. Several parame-
ters can be computed from these signals that provide
physiological information about the injured cord (Table 1).
It is important to note that we monitor ISP from the sub-
dural space, which is less invasive than intraparenchymal
ISP. When the injured cord is swollen and compressed
against the dura, subdural ISP equals intraparenchymal
ISP at the injury site [13, 17, 26]. After a mild TSCI, the
spinal cord may not be compressed against the dura; in
this case, the relation between subdural versus intrapar-
enchymal ISP is unknown. To date, we have only moni-
tored ISP from patients with severe TSCI.
It is also possible to perform multi-modality monitor-
ing by placing ISP and MD probes on the spinal cord
surface at the injury site [20]. In our recent study of 14
TSCI patients, we found that surface MD monitoring is
safe [20]. There was severe metabolic derangement at
the injury site that correlated with the severity of injury.
Below, we discuss how MD can be used to determine
the optimum spinal cord perfusion pressure (SCPPopt)
and optimum tissue glucose concentration as well as
maximize the penetration of systemically administered
drugs into the injury site.
Animal models
After TSCI in mice, the injured cord swells and is com-
pressed against the dura thus generating high ISP [12].
Mice that lack the water channel protein aquaporin-4
have reduced spinal cord edema after TSCI with im-
proved outcome. Reducing the elevated ISP in a rat
contusion TSCI model also improved outcome [27]. In a
pig contusion TSCI model, increased thecal sac dimen-
sions were associated with reduced cord compression and
reduced injury site ISP [28]. Durotomy reduced intrapar-
enchymal ISP after TSCI in ex-vivo pig spinal cords [29].
In a rat contusion TSCI model, durotomy with duroplasty
improved outcome more than durotomy without duro-
plasty [27]. After rat TSCI, durotomy without duroplasty
was associated with more macrophage accumulation, cys-
tic cavitation, and fibroblast proliferation than durotomy
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with duroplasty [30]. Dural continuity also prevented
epidural and spinal cord fibroblast proliferation and scar
formation. Together, the animal experiments suggest that
opening the dura is advantageous by relieving ISP, but a
dural patch is required to reduce spinal cord inflammation
and scarring. We have recently completed a phase II trial
of expansion duroplasty for TSCI, described below.
Novel clinical concepts
Intraspinal pressure and spinal cord perfusion pressure
Low MAP is detrimental by causing ischemic cell death.
Increasing MAP is, therefore, likely to be beneficial. Even
if the injury site is not viable, increasing MAP may still be
beneficial by preventing upward extension of the injury,
based on the idea of a critically ischemic penumbra. Re-
cent studies suggest that the duration of hypotension after
acute TSCI, defined as MAP <85 mmHg, correlates with
worse outcome [31], though use of vasopressors to treat
hypotension causes complications [32] especially in older
TSCI patients [33]. In our view, what actually matters is
not MAP, but MAP minus ISP, i.e., spinal cord perfusion
pressure (SCPP). Because of the lack of ISP monitoring to
date, the concept of SCPP has not been developed, but is
analogous to cerebral perfusion pressure (CPP) for TBI.
To re-phrase the first statement, low SCPP is probably
detrimental.
Fig. 1 Intraspinal pressure (ISP) monitoring technique. a (left) Insertion of ISP probe through the dura. (middle) Surgical wound showing drain and
ISP probe. (right) Postoperative computed tomography (CT) showing ISP probe. b (left) ISP signal. (inset) Magnified view of ISP waveform showing
three peaks (P1, P2, P3). (right) Fourier transform of ISP signal. Modified from [13]
Table 1 Comparison of brain and spinal cord physiological parameters
Brain parameter Spinal cord parameter Similarities Differences Reference
Intracranial pressure (ICP) Intraspinal pressure (ISP) ICP and ISP waveforms
similar with same three peaks
and similar Fourier transforms
Injury site ISP > ISP above
or below, but ICP similar
throughout. ICP but not ISP
reduced with mannitol or
hyperventilation.
[13, 17, 35, 44]
Cerebral perfusion pressure
(CPP) = MAP – ICP
Spinal cord perfusion pressure
(SCPP) =MAP – ISP
CPP and SCPP waveforms
similar. CPP and SCPP can be
increased with vasopressors
SCPP at injury site differs
from SCPP above or below,
but CPP similar in brain
[13, 17, 35, 44]
Optimum cerebral perfusion
pressure (CPPopt)
Optimum spinal cord
perfusion pressure (SCPPopt)
U-shape PRx vs CPP, sPRx vs
SCPP. Minimum is CPPopt or
SCPPopt. CPPopt and SCPPopt
individualized
Overall CPPopt ~75 mmHg
whereas overall SCPPopt
~90 mmHg
[13, 14, 17, 35, 44]
Pressure reactivity index (PRx) Spinal Pressure reactivity
index (sPRx)
Running correlation between
MAP and ICP/ISP
PRx is global, but sPRx is for
injury site
[13, 14, 35, 44]
Compensatory volume
reserve (RAP)
Spinal compensatory volume
reserve (sRAP)
Running correlation between
mean ICP/ISP and ICP/ISP
pulse amplitude
RAP is global, but sRAP is for
injury site
[13, 14, 35, 44]
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We have several lines of evidence that this is so. First
is the analogy between TBI and TSCI. After TSCI, SCPP
is low (typically <60 mmHg) [13]; TBI patients with
CPP <60 mmHg are at high risk of brain death [34]. Sec-
ond, increasing SCPP increases the limb motor score in
some AIS (American spinal injuries association Impairment
Scale) grade C patients [13] and improves the sensory
level in some AIS grade A patients (Fig. 2). Third, increas-
ing SCPP increases the amplitude of motor evoked poten-
tials recorded from below the injury in AIS grade C
patients or just above the injury in AIS grade A patients
[13]. Fourth, increasing SCPP improves spinal cord auto-
regulation [13, 14]. Fifth, increasing SCPP is associated
with increased nutrient supply (tissue glucose), reduced
cell membrane lysis (glycerol), excitotoxicity (glutamate),
and tissue ischemia (lactate-to-pyruvate and lactate-to-
glucose ratios). Sixth, increasing SCPP is associated with
increased blood flow to the injury site [13]. Together,
these data suggest that the injured spinal cord is ischemic
and that increasing SCPP reduces ischemia. Below we
show that too high a SCPP may be detrimental.
There are clinically important differences between ICP
versus ISP and CPP versus SCPP (Table 1) [13]. Increas-
ing the dose of sevoflurane from 1.0 to 1.5 minimum
arteriolar concentration causes ICP to rise, but does not
affect ISP. Reducing paCO2 by 1 kPa, which reduce ICP
by vasoconstriction, does not influence ISP. Administer-
ing an intravenous 100 mL bolus of 20 % mannitol re-
duces ICP, but not ISP. The only medical maneuver that
increases SCPP is increased dose of vasopressors. There-
fore, the therapeutic options to improve perfusion at the
injury site are limited for TSCI compared with TBI.
Pressure reactivity and compensatory reserve
Pressure reactivity is the ability of smooth muscle in the
walls of arteries and arterioles to respond to changes in
arterial pressure to keep blood flow constant. We define
spinal pressure reactivity index (sPRx) as the running
correlation coefficient between ISP and MAP. There-
fore, –1 ≤ sPRx ≤ +1. When sPRx ≤0, spinal cord pressure
reactivity is intact and when sPRx >0, pressure reactivity is
impaired. sPRx for TSCI is analogous to the pressure
reactivity index (PRx) for TBI [25, 35].
The Monro-Kellie doctrine states that inside the adult
skull there is blood, cerebrospinal fluid (CSF), and brain
tissue in a state of volume equilibrium; an increase in
volume of one component is compensated by an equiva-
lent decrease in volume of another. A small increase in
brain volume does not lead to increases in ICP because
CSF and venous blood are displaced into the spinal
canal. Once the ICP is ~25 mmHg, small increases in
brain volume cause marked elevations in ICP. This is
the basis of an exponential relationship between ICP and
intracranial volume and the concept of RAP, which is a
running correlation coefficient (R) between mean ICP
amplitude (A) and ICP pulse amplitude (P). RAP ~0
indicates good compensatory reserve, whereas RAP ~1
indicates that ICP rises greatly with a small increase in
volume [25]. Here, we argue that the Monro-Kellie doc-
trine may also apply to the injured cord. After severe
TSCI, the pia is damaged, evidenced by the observations
that the injured cord appears swollen on MRI [16] and,
at the injury site, subdural ISP equals intraparenchymal
ISP [17]. Spinal cord swelling may generate forces radi-
ally and rostro-caudally. Since most neuronal fibers run
rostro-caudally, cord edema will produce radial rather
than rostro-caudal cord expansion. The denticulate liga-
ments and nerve roots may also restrict rostro-caudal
cord expansion. If rostro-caudal spinal cord expansion
were possible, then the spinal cord above the injury
would be displaced upward whereas the spinal cord
below the injury would be displaced downward. Such
displacements are not seen on MRI scans; instead, there
is radial swelling of the injured cord against the dura.
The observations that, after a laminectomy, the dural
sac diameter at the injury site appears the same as above
or below, and that ISP at the injury site remains high,
suggest that the spinal dura is non-distensible. Thus, as
the injured cord swells, the compensatory mechanisms
of displacing CSF and venous blood become exhausted
Fig. 2 Spinal cord perfusion pressure (SCPP) correlates with outcome.
a Plot of total limb neurological score versus SCPP for two AIS grade C
TSCI patients. b Change in sensory level to pinprick in response to
change in SCPP. Modified from [13]
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and ISP rises. This means that the injury site probably
obeys the Monro-Kellie doctrine and the concept of
compensatory volume reserve likely applies, quantified
using spinal RAP (sRAP) by analogy with brain RAP
[13, 14]. sRAP ~0 indicates good pressure-volume com-
pensatory reserve and, when RAP ~1, the swollen spinal
cord is on the steep part of the pressure-volume curve.
We showed that as ISP rises >10 mmHg, sRAP increases,
and as SCPP rises >40 mmHg, sRAP decreases [13, 14].
Overall optimum spinal cord perfusion pressure
If we continue to increase SCPP, there must be a point be-
yond which SCPP becomes detrimental. Mechanisms of
over-perfusion injury include increased spinal cord edema
and intraparenchymal hemorrhage. Since too low and too
high values of SCPP are detrimental, there must exist an
optimum spinal cord perfusion pressure (SCPPopt) in
between.
We define SCPPopt as the perfusion pressure that
minimizes sPRx. A plot of the sPRx against SCPP gives a
U-shaped relationship, which supports the notion that not
only hypo-perfusion, but also hyper-prefusion is detrimen-
tal [25, 35]. The minimum of the sPRx versus SCPP curve
is the SCPP at which the injury site autoregulates best, i.e.,
SCPPopt. We showed that SCPPopt is approximately
90 mmHg (Fig. 3a) [13, 18]. Autoregulation is abnormal
even at SCPPopt because sPRx >0. A U-shaped relationship
also exists between PRx and CPP in severe TBI. The brain
is more extensively vascularized than the spinal cord,
which may explain why, in general, optimum cerebral
perfusion pressure (CPPopt) is less than SCPPopt at
70–75 mmHg. Compared with TBI patients managed at
CPP near CPPopt, those managed below CPPopt have
higher mortality whereas those managed above CPPopt
have more severe disabilities [36]. The effect on neuro-
logical outcome of managing TSCI patients above or
below SCPPopt is unknown. SCPPopt can also be defined
as the SCPP that optimizes injury site metabolism (i.e.,
highest glucose, lowest glutamate, lowest glycerol, lowest
lactate-to-pyruvate and lactate-to-glucose ratios). MD data
after TSCI suggest that SCPPopt = 90–100 mmHg [20],
similar to the SCPPopt determined from sPRx.
Let us put this SCPPopt in context. After severe TSCI,
ISP is typically 20–40 mmHg. Therefore, to achieve SCPP
of ~90 mmHg, MAP has to be 110–130 mmHg, which is
substantially higher than the MAP of 85–90 mmHg rec-
ommended by the American Association of Neurological
Surgeons [10]. Most patients have a cervical injury and
are, therefore, hypotensive from damage to the sympa-
thetic pathways. To maintain MAP 110–130 mmHg,
high-dose vasopressors are required, which are associated
with drug-related complications [32]. One way to reduce
the dose of vasopressors is by surgical decompression, dis-
cussed in detail below (‘Dural spinal cord compression’).
Patient-specific optimum spinal cord perfusion pressure
Figure 3a shows sPRx against SCPP by combining data from
several patients. Most patients have their own U-shaped
curve and individualistic SCPPopt (Fig. 3b). Factors that may
contribute to the variability of SCPPopt between patients
include the extent of microvascular damage, pre-existing
hypertension, mechanism of injury, and genotype. The
spinal cord metabolic response to injury is also patient-
specific [21]. The concept that SCPPopt and injury site me-
tabolism vary between patients suggests that universal
Fig. 3 Spinal pressure reactivity index (sPRx) and optimum spinal
cord perfusion pressure (SCPPopt). a Plot of sPRx versus SCPP for 18
patients. b Individual plots of sPRx versus SCPP for two patients. The
minimum value corresponds to SCPPopt. Adapted from [13] and [18]
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management protocols are insufficient and that neuromoni-
toring is essential to achieve individualized management.
Injury site compartmentalization
By monitoring two pressures simultaneously [13], or ISP
along the injured cord [17], we showed that three intra-
dural compartments form after severe TSCI: 1) above
the injury; 2) at the injury; and 3) below the injury [15]
(Fig. 4a). These compartments do not communicate be-
tween themselves; therefore, each compartment has a
different pressure. The highest ISP is at the injury site
where the swollen, injured cord is compressed against
the dura. Because of compartmentalization, monitoring
CSF pressure from below the injury does not provide in-
formation about ISP at the injury site. Draining CSF
with a lumbar catheter has been proposed as a treatment
for TSCI [37]. CSF drainage is unlikely to improve SCPP
in TSCI because, at the injury site, there is no CSF
around the spinal cord. In 65 patients with TSCI, 63
(97 %) had cord compression on MRI; compression was
extradural in 75 % and dural in 25 % [16]. After bony de-
compression, most patients still had high ISP [13, 18],
suggesting dural cord compression in most. Two other
lines of evidence support the lack of communication
between the CSF compartments above and below the in-
jury. After TSCI, little CSF can be drained from the lum-
bar region and, when the lumbar drain is transduced,
there is a non-pulsatile signal [37]. Draining CSF
through a lumbar catheter is also potentially detrimental
by causing downward herniation of the injured cord.
Compartmentalization may be a feature of the severity
of TSCI and the surrounding CSF space; if TSCI is mild
or the CSF space is large, the spinal cord will not be
compressed by the dura and, therefore, the three com-
partments will not form. It is unknown if, in the first
few days after TSCI, compartmentalization is constant
or dynamic or if compartmentalization is more common
in some TSCI types, e.g., flexion/distraction.
Dural spinal cord compression
Why is bony decompression for TSCI controversial? The
answer may be the dura surrounding the damaged cord,
which is poorly distensible. Even if early bony decom-
pression is performed, the swollen cord remains com-
pressed against the dura. Dural spinal cord compression
explains why ISP at the injury site remains high even
after realignment of the spinal fracture, fixation, and
laminectomy [13, 18]. The concept of dural compression
is well established for TBI, where decompressive cra-
niectomy involves not only removing bone but also
opening the dura.
The idea of dural compression is not appreciated after
TSCI, though compression of the swollen, injured spinal
cord against the surrounding dura is evident on
Fig. 4 Expansion duroplasty. a Three intradural compartments form after TSCI—above, at, and below the injury site. b Intraoperative photo
showing duroplasty. D dura, DP dural patch. c Postoperative MRI showing the swollen, injured cord herniating into the duroplasty. d Intraspinal
pressure (ISP) and e spinal cord perfusion pressure (SCPP) versus days after injury for 10 patients who had laminectomy and 11 patients who had
laminectomy + duroplasty. Mean ± standard error. *P < 0.05. Adapted from [13] and [18]
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postoperative MR scans [13, 16, 18] (Fig. 4a). The term
‘spinal decompression’ refers to removing extradural
compression such as bone fragments without opening
the dura, whereas the term ‘brain decompression’ refers
to removing bone and opening the dura. Surgeons
developed the concept of spinal decompression to treat
degenerative spinal diseases such as canal stenosis where
neural tissue is compressed from outside the dura.
Unlike degenerative spinal pathologies, however, in TSCI
the damaged spinal cord itself is swollen against the sur-
rounding dura and, therefore, dural spinal cord decom-
pression is essential. We, therefore, propose that the
concept of decompression for TSCI be modified to include
opening the dura. Serial MR scans of TSCI patients indi-
cate that dural spinal cord compression resolves with a
half-life of 8.7 days [16]. The slow rate of resolution of
dural spinal cord compression supports early surgical
decompression to reduce prolonged use of vasopressors.
We have recently conducted a phase II non-randomized
trial comparing laminectomy versus laminectomy plus
expansion duroplasty (Fig. 4b–e) [13, 16, 18]. After lamin-
ectomy plus expansion duroplasty, the injured cord herni-
ates into the extra space that has been created, which
suggests that the swollen cord was compressed by the dura.
Laminectomy plus expansion duroplasty decompressed the
injured cord more effectively than laminectomy without
duroplasty, as evident on MRI. Laminectomy plus expan-
sion duroplasty also reduced ISP, increased SCPP, and
lowered the sPRx versus SCPP curve downward with the
minimum at 90 mmHg. Duroplasty takes about 10–15 min
to perform and is safe; the main side effect is asymptomatic
pseudomeningocele in about half of patients that resolves
within 6 months. This study was powered to detect an in-
crease in dural diameter, spinal cord decompression by
MRI, a reduction in ISP and sPRx, as well as an increase in
SCPP, but was underpowered to detect neurological
improvement.
Nursing care: lying supine may be detrimental
In patients who have had laminectomy, wound compres-
sion increases ISP and reduces SCPP due to transmis-
sion of the compressive forces to the cord [13]. The ISP
rise was up to 20 mmHg, enough to aggravate cord
damage. Lying supine is also associated with higher ISP,
by 2–4 mmHg, compared with lying laterally [18]. This
pressure difference was more marked for thoracic than
cervical TSCI [19], probably because, when supine, the
cervical cord is less compressed due to its lordosis
whereas the kyphotic thoracic cord becomes more com-
pressed. No difference in ISP or SCPP was observed in
non-laminectomized patients. In one thoracic TSCI pa-
tient, the difference in ISP between supine and lateral
position was 18 mmHg [19]. These findings suggest that,
after TSCI, patients who had laminectomy should be
nursed on their side to avoid aggravating cord damage
by increasing ISP and reducing SCPP.
Neuroprotective drug trials
Issues to consider when designing drug trials for TSCI have
been described elsewhere [38–41]. Patient age, site and se-
verity of injury, and rehabilitation influence outcome. Such
heterogeneity means that many patients are required. The
formation of clinical networks may facilitate patient re-
cruitment into trials, whereas MR imaging and electro-
physiological outcome measures may reduce the number of
patients required. Another issue is penetration of systemic-
ally administered drugs into the injury site, especially since
patients with severe cervical TSCI are hypotensive with
high ISP. Though the blood-spinal cord barrier opens after
acute TSCI thus favoring drug entry into the injury site, we
have recently shown that SCPP is also a major, but un-
appreciated, determinant of drug entry [20]. An increase in
SCPP by 10 mmHg increases dexamethasone penetration
into the injury site three-fold. Ongoing trials of minocycline
and riluzole [42] as well as completed drug trials of methyl-
prednisolone [6, 7] have not optimized SCPP. It is possible
that drug trials for acute TSCI fail because of inadequate
drug penetration at the injury site.
Limitations
At present, our unit is the only one that performs neuro-
monitoring; it is vital that others reproduce our findings.
With our technique, probes are inserted intraoperatively,
which limits their use. In the future, the method should be
refined to insert probes percutaneously in the NICU. This
will allow neuromonitoring to start earlier and widen its
use to non-TSCI, such as edematous transverse myelitis
where not only inflammation but also ischemia may play a
role [43]. Several of the concepts we introduced, such as
SCPPopt, make physiological sense, but are presently theor-
etical. Evidence is required that SCPPopt has clinical value,
e.g., by showing that patients managed with SCPP close to
SCPPopt have better outcomes than those with large SCPP
deviation from SCPPopt. Even if SCPPopt is clinically im-
portant, it is computed after the monitoring has finished; a
continuous SCPPopt is required, which is displayed in real-
time in the NICU. Another issue is timing of surgery,
which is delayed in many units. It is, therefore, unknown if
ultra-early bony decompression prevents cord swelling
thus precluding the need for ISP monitoring or duroplasty.
With further studies, these limitations can be overcome.
Conclusions
We describe how monitoring from the injury site may
guide the management of TSCI. Ultimately, a randomized
controlled trial is required to determine if monitoring and
SCPP optimization improve outcome, which can only be
achieved by international collaboration.
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